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Abstract
Background: During the last decade, thromboelastography (TEG) has gained increasing acceptance as a diagnostic 
test in veterinary medicine for evaluation of haemostasis in dogs, however the use of TEG in cats has to date only been 
described in one previous study and a few abstracts. The objective of the present study was to evaluate and compare 
three different TEG assays in healthy cats, in order to establish which assay may be best suited for TEG analyses in cats.
Methods: 90 TEG analyses were performed on citrated whole blood samples from 15 clinically healthy cats using 
assays without activator (native) or with human recombinant tissue factor (TF) or kaolin as activators. Results for 
reaction time (R), clotting time (K), angle (α), maximum amplitude (MA) and clot lysis (LY30; LY60) were recorded.
Results: Coefficients of variation (CVs) were highest in the native assay and comparable in TF and kaolin activated 
assays. Significant differences were observed between native and kaolin assays for all measured parameters, between 
kaolin and TF for all measured parameters except LY60 and between native and TF assays for R and K.
Conclusion: The results indicate that TEG is a reproducible method for evaluation of haemostasis in clinically healthy 
cats. However, the three assays cannot be used interchangeably and the kaolin- and TF activated assays have the 
lowest analytical variation indicating that using an activator may be superior for performing TEG in cats.
Background
Monitoring of coagulation has traditionally been based
on prothrombin time (PT) and activated partial thrombo-
plastin time (aPTT). These tests can serve as global
screening methods for certain coagulation factors, diag-
nostically localizing a defective function in either the
intrinsic or extrinsic coagulation pathways. However,
they provide only limited information on the overall hae-
mostatic capability of the patient [1]. In addition, parame-
ters such as fibrinogen degradation products (FDPs) and
D-dimers have been used to evaluate the extent of fibrin-
olysis with measurement of D-dimers as the only diag-
nostic test for detection of breakdown of cross linked
insoluble fibrin. Despite the ability to detect fibrin/fibrin-
ogen degradation products, these tests have not been rec-
ommended as the sole tests to evaluate the role of
fibrinolysis in overall haemostasis [2]. Finally, the impact
of different cell types on haemostasis is completely lack-
ing in plasma-based tests.
During the last decade, a new model of haemostasis,
the cell-based model, has gained increased acceptance.
This model is based on the three associated processes:
initiation, amplification and propagation followed by
fibrinolysis. Initiation takes place on tissue factor (TF)-
bearing cells, whereas amplification and propagation
occurs on the surface of platelets with thrombin produc-
tion and fibrin polymerization as the final result [3].
Development of this model has led to a better under-
standing of physiological and pathological mechanisms
influencing the haemostatic balance.
Thromboelastography (TEG) is a point of care tech-
nique performed on whole blood, which measures the
viscoelastic properties during clot formation and break-
down in a low shear environment [4]. The technique was
developed in 1948 and has gained wide use in human
medicine over the last decade [5-7]. In veterinary medi-
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cine, TEG has been subject to increasing interest in the
last few years [8]. The technique has been validated for
haemostasis monitoring in dogs, followed by studies
proving the clinical relevance of TEG in this species [9-
13]. It is expected that the same can be achieved in cats.
A few studies published only as abstracts have sug-
gested that TEG can serve as a diagnostic tool in cats [14-
16]. However, to the best of our knowledge, no full stud-
ies validating TEG in this species have been published
and haemostasis monitoring in cats is therefore currently
almost exclusively limited to coagulation tests, which
reflect the functionality of the plasma components of the
blood such as PT and aPTT. Consequently, evaluation of
haemostasis in diseases like feline cardiomyopathy, a dis-
ease known to predispose to hypercoagulability and
thromboembolism, is difficult due to the lack of diagnos-
tic tests that can reliably identify hypercoagulability and
global haemostatic imbalances [17].
The overall purpose of this study was to evaluate ana-
lytical performance of three TEG assays: native (without
activator added), human recombinant tissue factor (TF)
activated and kaolin activated respectively differing from
each other only by mode of initiation of coagulation.
Materials and methods
Recruitment and sampling
The study was conducted between March 30th and April
30th 2009 at the Small Animal Hospital, Department of
Small Animal Clinical Sciences, Faculty of Life Sciences
(KU-LIFE), University of Copenhagen, and all haemato-
logical analyses were performed at The Clinical Pathol-
ogy Laboratory at the department. The study was
approved by the Small Animal Ethics and Administrative
Committee. Blood samples were collected from 22 clini-
cally healthy cats belonging either to students or staff or
to owners who had previously shown interest in letting
their cat participate in clinical studies at the department.
Owners were informed about the study by an information
letter and were asked to sign a statement confirming their
agreement of participation. The health status of the cats
was determined by clinical examination as well as unre-
markable results on a Complete Blood Count (CBC)
(Advia 120, Siemens), a biochemistry panel (Advia 1800,
Siemens) and a coagulation profile (ACL TOP 500,
Instrumentation Laboratories). All results were assessed
by a clinical pathologist.
Blood samples were collected by jugular venipuncture
using a 21 Gauge butterfly needle. Blood was collected
into one 3 mL serum, two 3 mL trisodium citrate (3.2%,
0.109 M) and one 2 mL EDTA plastic tubes (Vacuette,
Greiner Bio-One International AG) in that order. Imme-
diately after collection, the citrated tubes were inverted
carefully five times to ensure adequate mixing of citrate
and blood. Citrated tubes for TEG analyses were left in a
standing position for 30 min at room temperature (20-
25°C) before TEG analyses. Standard coagulation profile
was performed on citrated plasma after centrifugation at
4400 g for 3 min and consisted of an aPTT (aPTT Syn-
thAFax, Instrumentation Laboratories), PT (PT-Fibrino-
gen, Instrumentation Laboratories), fibrinogen (PT-
Fibrinogen, Instrumentation Laboratories) and D-Dimers
(D-Dimer Single T ests, NycoCard READER II, Medinor
A/S).
TEG analysis
Analyses were performed using a computerized throm-
boelastograph (TEG® 5000 Haemostasis Analyzer, Hae-
monetics Corporation). Data was directly transferred to a
computer and results were displayed graphically and
recorded in a database.
Duplicate whole blood samples were analyzed in paral-
lel using TF, kaolin and native assays respectively for each
cat giving a total of six TEG analyses per cat. The analyses
were performed in the mentioned order using pre heated
TEG cups (37°C) with addition of 20 μL 0.2 M CaCl2 prior
to addition of citrated whole blood (WB). TF was pro-
duced by dilution of human recombinant tissue factor
(Innovin, Siemens AG) in a 4-(2-hydroxyethyl)-1-pipera-
zine ethanesulfonic acid (HEPES) buffer with bovine
serum albumin. 25 μL diluted TF was mixed with 400 μL
citrated WB and 340 μL of this mixture were added to the
TEG cups yielding a final TF:WB ratio of 1:50,000. Kaolin
activated WB was prepared by adding 1 mL citrated WB
to kaolin primed tubes (Haemonetics Corporation) and
340 μL of this mixture was added to the TEG cups. For
native analysis 340 μL citrated WB was added directly to
the TEG cups.
Immediately after addition of WB, the cup was raised to
the pin and measurement was initiated. Six TEG parame-
ters were investigated: R, K, α, MA, LY30 and LY60. R is
the time span from initiation until the first fibrin poly-
mers are produced. The cut-off value is when the ampli-
tude reaches 2 mm. K is the time until an amplitude of 20
mm is reached representing the speed of clot formation.
α is the angle representing the acceleration and thus
kinetics of the fibrin production and cross-linking. MA is
the maximum amplitude, reflecting the maximal clot
strength [6,18]. LY30 and LY60 are the percent clot lysis
detected at 30 and 60 min after MA is reached respec-
tively [18].
The first four parameters reflect different incidents
during clotting: R time is dependent on the action of
coagulation factors; K time is dependent on the action of
coagulation factors, fibrinogen and platelets; the α-angle
is dependent on the action of fibrinogen, the platelet
function and the platelet membrane composition andMarschner et al. Acta Veterinaria Scandinavica 2010, 52:38
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MA is dependent on the platelet/fibrin interactions
[6,8,18]. LY30 and LY60 percentages depend on the
fibrinolytic activity [18].
Statistical analysis
Statistical analyses were performed using GraphPad
Prism 5 (GraphPad Software Inc.).
Coefficients of Variation (CVs) for the four parameters
were determined using the arithmetic mean and variance
estimate, the latter based on the difference between the
duplicate samples.
Distribution of the data was determined using D'Agos-
tino-Paerson normality test. Repeated measures ANOVA
followed by a Tukey's Multiple Comparison Test was used
to analyze normally distributed data and a Freidman's test
followed by a Wilcoxon signed rank test was used to ana-
lyze non-parametric data with the null-hypothesis that
there was no difference between any of the three assays
with regard to the six parameters. Statistical significance
level was set at 0.05.
Results
Of the 22 cats, 7 were excluded due to: missing data (n =
3), ulcerated cutaneous tumour (n = 1), abnormal bio-
chemical results (n = 2) and inadequate blood flow for
T E G  a n a l y s i s  d u r i n g  b l o o d  s a m p l e  c o l l e c t i o n  ( n  =  1 ) .
CBC, biochemistry and coagulation profiles for the 15
remaining cats were unremarkable. Results for coagula-
tion profiles are shown in Table 1.
Of the 15 included cats, 10 were castrated males, 4 were
spayed females and 1 was an intact female and consisted
of the breeds Domestic Short Hair (n = 9), Birman (n = 2),
British Short Hair (n = 1), Maine Coon (n = 1), Siamese (n
= 1), and Rag Doll (n = 1). The mean age of the study pop-
ulation was 3.3 y (0.11-7.9 y).
The normality test revealed that results obtained for
the parameters K and LY30 were not normally distrib-
uted. The arithmetic mean, range and the CV for the six
parameters are shown in Table 2. There were statistically
significant differences between the three assays for R (P <
0.0001), K (P = 0.0027), α (P = 0.0003), MA (P < 0.0001),
LY30 (P = 0.0077), and LY60 (P = 0.001). Tukey's Multiple
Comparison Test of R, α, MA, and LY60 showed signifi-
cant differences (P < 0.05) between native and kaolin for
all four parameters, between native and TF for R but not
for α, MA or LY60 and between TF and kaolin for R, α,
and MA, but not for LY60. Wilcoxon signed rank test
showed that there was significant differences for K
between native and TF (P = 0.0052), native and kaolin (P
= 0.002) and between TF and kaolin (P = 0.0041) and for
LY30 between native and kaolin (P = 0.0076) and TF and
kaolin (P = 0.0049) but not between native and TF.
Discussion
The present study demonstrates that TEG is a reproduc-
ible method for evaluation of haemostasis in clinically
healthy cats, when any of the three assays native, TF or
kaolin is used. Statistical analyses showed that there are
significant differences between all six parameters when
comparing the native and kaolin assays. Likewise, all
parameters are significantly different when comparing TF
and kaolin assays with the exception of LY60, whereas the
difference between the TF activated and native assays is
related solely to the initiation phase of coagulation (R and
K). The study suggests that the results obtained with the
three assays cannot be used interchangeably. Of the three
assays, native has the highest CV in all six parameters,
whereas kaolin has the lowest CV in all six parameters.
The finding of a larger analytical variation in the results
using the native assay compared to TF based or kaolin
based assays was expected especially regarding the R and
K parameters since initiation of coagulation in the native
assay occurs spontaneously and not as a result of activa-
tion by a standardized amount of either TF or kaolin. The
finding of a high variation using the native assay corre-
lates well with the results obtained in a previous study in
cats [19]. In addition, the CVs for R, K, α, and MA for the
TF based and kaolin based assays calculated in our study
are well in accordance with CVs reported when using TF
activated TEG in dogs as well as using kaolin and TF acti-
vated TEG in humans [9,20].
It was expected that the kaolin based assay would differ
significantly from the TF based assay. Significant differ-
ences between kaolin and TF activated TEG have been
reported for K, α and MA in a previous study [15]. The
results obtained in the present study show that kaolin
based assays differ from TF based assays by significantly
shorter R and K values as well as significantly higher α
Table 1: Coagulation profiles in 15 clinically healthy cats
Fibrinogen (g/L) PT (sec) APTT (sec)* D-dimer (mg/L)
Mean 1.90 10.29 20.24 0.19
Range 1.33-2.62 9.4-11.5 12-33.8 0.1-0.6
The profile includes fibrinogen and D-dimer concentrations. Prothombin time (PT) and activated partial thromboplastin time (APTT) are given 
in seconds.
*Number of cats = 14.Marschner et al. Acta Veterinaria Scandinavica 2010, 52:38
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and MA values suggesting that kaolin is a more potent
activator than diluted human recombinant TF in cats.
Mechanisms by kaolin and TF activation on the coagula-
tion in cats remain to be investigated. Since TF is recog-
nized as the initiator of coagulation in vivo according to
the cell based model of haemostasis, TF activated TEG
analyses may provide a better in vitro estimate of in vivo
coagulation. On the other hand the kaolin based assay is
the safest method regarding risks of pre-analytical errors,
since ready-to-use kaolin tubes are provided by the man-
ufacturer and thus easily accessible, whereas human
recombinant TF must be prepared from a concentrated
stock on a daily basis, leading to a larger risk of inter-
assay variation when using this assay.
The results for K, α, and MA in the native assay are
comparable to findings obtained in one other study using
native TEG in cats [16]. However, only MA results are
similar when compared to a second study using the native
TEG assay [19]. Since both these studies are published in
abstract form only, a thorough comparison of the meth-
ods used and thus results obtained is difficult.
Conclusions
The results indicate that TEG is a reproducible method
for evaluating haemostasis in clinically healthy cats. The
present study shows that TEG analyses using TF- or
kao lin based as sa ys a r e  l ik e l y t o be  m or e  r e lia bl e  t han
results obtained using the native assay. The results from
the present study, with regard to analytical variation of LY
values, indicate that the native assay is inferior when
compared to the TF based and kaolin based assay. It must
be emphasized that comparison of results obtained from
the three different TEG assays should be avoided due to
the significant differences between the assays docu-
mented in the present study. It is therefore recommended
that each laboratory use only one assay for routine analy-
ses in order to keep a standardized working procedure.
Prospective studies are needed to evaluate the clinical
usefulness of the three assays in cats.
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Table 2: Thromboelastograph measurements in 15 clinically healthy cats  
Group R minutes K† minutes α degrees MA
mm
LY30† %* LY60
%*
N a t i v e M e a n 1 0 . 0 63 . 5 54 9 . 2 3 5 0 . 8 30 . 1 8 2 . 9 7
Range 3.3-19.8 1.9-6.6 32.5-64.6 38.3-60.7 0.0-4.0 0.0-8.9
CV (%) 9.96 15.04 7.76 4.09 193.93 100.31
TF Mean 7.46 2.85 53.20 52.41 0.30 4.25
Range 3.2-12.5 1.9-5.8 34.1-64.3 40.3-62.8 0.0-5.6 0.1-10.5
CV (%) 8.29 11.34 7.08 2.86 25.12 14.15
Kaolin Mean 5.57 2.00 61.83 56.61 1.05 5.41
Range 2.4-9.5 1.2-3.9 45.5-73.5 46.8-66.1 0.0-9.0 1.1-13.1
CV (%) 6.42 14.80 3.65 2.57 17.54 12.10
Measurements were done without activator (native) as well as with tissue factor (TF) or kaolin as activators.
R = reaction time; K = clotting time; α = angle; MA = maximum amplitude; LY30 = clot lysis 30 min after MA is reached; LY60 = clot lysis 60 min 
after MA is reached.
†Median.
*Mean, range and CV% calculated using the results obtained in 14 cats. TEG analyses on feline citrated whole blood in our department prior 
to this study have occasionally revealed a distinct TEG trace pattern showing increased LY values, a finding that has been encountered 
previously [16]. In this study the encountered pattern in question only appeared once leading to exclusion of the LY data of one cat.Marschner et al. Acta Veterinaria Scandinavica 2010, 52:38
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